Guardian Health Sciences Inc. [NASDAQ: GHSI] The stock went on an uptrend that gained over 3.90% on Wednesday, showing a one-week price gain of over 9.59%. Guardian Health Sciences announced financial results for the three months and nine months ended September 30, 2022, the company reported on November 14, 2022.
China Can’t Stop US$0.25 Of Stock From Mining The Ultra-Rare Metal
Here’s a tiny company—trading at an unheard-of below 25-cents per share—that is developing one of the largest and highest-quality REE deposits in all of North America…and the Chinese are all about it. Can’t do anything! It’s early stages… and that’s great news for individual investors like you who have the foresight to act decisively on an emerging megatrend that is already being measured in the tens of billions of dollars.
Just click here and the name and trading symbol is yours.
Viactive® generated net revenue of approximately $2.6 million or 96% of net revenue for the quarter ended September 30, 2022.
In the past 12 months, GHSI stock declined -85.19%. The Average Equity Rating for GHSI stock is currently 2.00 which is trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $9.80 million, with 61.60 million shares outstanding and 60.78 million shares in the current float. Compared to the average trading volume of 1.34M shares, GHSI stock reached a trading volume of 285096 in the most recent trading day, which is why market watchdogs consider the stock as active.
Guru’s Opinion on Guardian Health Sciences Inc. [GHSI],
Guardian Health Sciences Inc. The Average True Range (ATR) for GHSI stock is set at 0.01, with a price to sales ratio of 0.86 for GHSI stock over the trailing 12-month period. The Price to Book ratio for the previous quarter was 0.37.
GHSI Stock Performance Analysis:
Guardian Health Sciences Inc. [GHSI] Reached the green zone at the end of last week, in a positive trend and with a gain of 9.59. With this latest performance, shares of GHSI are down -0.50% over the past four-week period, as well as down 7.45% over the past 6 months — not to mention a -85.19% decline over the past year of trading. Is.
Overbought and oversold stocks can be easily detected with the Relative Strength Index (RSI), where an RSI result of over 70 will result in overbought, and any rate below 30 will indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for the GHSI stock for the past two-week period is set at 51.99, with the RSI for the last one trading hit 54.57, and the three-week RSI for Guardian Health Sciences Inc. is set at 51.25. [GHSI], The current moving average for the last 50 days of trade of this stock is 0.1567, while it was recorded at 0.1494 for the last one week of trade and 0.1850 for the last 200 days.
Guardian Health Sciences Inc. Insight into the fundamentals:
The operating margin for any stock indicates how profitable an investment will be, and Guardian Health Sciences Inc. [GHSI] The shares currently has an Operating Margin of -144.94 and Gross Margin of +41.74. Guardian Health Sciences Inc. The Net Margin is currently recorded at -342.11.
The Return on Equity for this stock decreased to -160.61 while the Return on Assets stood at -148.52.
Equally interesting is the liquidity data of Guardian Health Sciences Inc., which has a quick ratio of 9.10 and a current ratio set at 10.30.
Guardian Health Sciences Inc. [GHSI] internal status statement
Institutional investors currently hold approximately $1 million, or 7.70%, of GHSI stock in hand. The top three institutional holders of GHSI stock are: RENAISSANCE TECHNOLOGIES LLC with ownership of $1,723,950, which accounts for approximately 9.475% of the company’s market cap and approximately 1.34% of total institutional ownership; Millennium Management LLC holds 816,897 shares of stock with an approximate value of $0.13 million in GHSI stock shares; and BLACKROCK INC., currently with $80000.0 in GHSI stock together owning around 0% of the company’s market capitalization.
Shares of Guardian Health Sciences Inc. held by institutional investors increased at the end of November and during the November reporting period, where 11 institutional holders increased their positions in Guardian Health Sciences Inc. [NASDAQ:GHSI] By approximately 1,190,856 shares. Additionally, 6 investors reduced positions totaling approximately 925,681 shares, while 7 investors held positions totaling 2,651,554 shares. As per the latest SEC report filing, the mentioned changes put the institutional holdings at 4,768,091 shares. There were 4 new institutional investments in GHSI stock for a total of 197,562 shares, while 2 institutional investors sold 64,576 shares during the same period.